Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk
about
Longitudinal changes in PON1 enzymatic activities in Mexican-American mothers and children with different genotypes and haplotypesJupiter to earth: a statin helps people with normal LDL-C and high hs-CRP, but what does it mean?Genetics of coronary artery disease and myocardial infarctionHigh density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular riskApolipoprotein A-I and CancerAntioxidant properties of HDLGenomic approaches to identifying targets for treating β hemoglobinopathiesThe human paraoxonase gene cluster as a target in the treatment of atherosclerosisRecent progress in the genetics and epigenetics of paraoxonase: why it is relevant to children's environmental healthInflammation, infection, cancer and all that…the role of paraoxonasesHigh-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literatureTrimethylamine-N-oxide, a metabolite associated with atherosclerosis, exhibits complex genetic and dietary regulationOrganophosphate pesticide levels in blood and urine of women and newborns living in an agricultural communityThe cardioprotective protein apolipoprotein A1 promotes potent anti-tumorigenic effectsValidation of PON1 enzyme activity assays for longitudinal studiesDevelopmental changes in PON1 enzyme activity in young children and effects of PON1 polymorphismsHuman paraoxonase-1 (PON1): Gene structure and expression, promiscuous activities and multiple physiological rolesAssociations of PON1 and genetic ancestry with obesity in early childhoodParaoxonase 1 gene polymorphism does not affect clopidogrel response variability but is associated with clinical outcome after PCIParaoxonase 1 and homocysteine metabolism.Association of scavenger receptor class B type I polymorphisms with subclinical atherosclerosis: the Multi-Ethnic Study of AtherosclerosisProgression of coronary atherosclerosis in African-American patientsPLTP activity inversely correlates with CAAD: effects of PON1 enzyme activity and genetic variants on PLTP activityParaoxonases function as unique protectors against cardiovascular diseases and diabetes: Updated experimental and clinical data.In vivo administration of BL-3050: highly stable engineered PON1-HDL complexesBoth paraoxonase-1 genotype and activity do not predict the risk of future coronary artery disease; the EPIC-Norfolk Prospective Population Study.Effect of efavirenz on high-density lipoprotein antioxidant properties in HIV-infected patients.Persistent DNA methylation changes associated with prenatal mercury exposure and cognitive performance during childhoodProtein biomarkers of new-onset cardiovascular disease: prospective study from the systems approach to biomarker research in cardiovascular disease initiative.First survey of the three gene polymorphisms (PON1 Q192R, eNOS E298D and eNOS C-786T) potentially associated with coronary artery spasm in African populations and comparison with worldwide data.Estradiol enhances cell-associated paraoxonase 1 (PON1) activity in vitro without altering PON1 expression.The genetics of vascular complications in diabetes mellitus.Investigation of 95 variants identified in a genome-wide study for association with mortality after acute coronary syndromeEffects of dietary components on high-density lipoprotein measures in a cohort of 1,566 participants.Anti-psoriatic therapy recovers high-density lipoprotein composition and function.Effects of cytochrome P450 2C19 and paraoxonase 1 polymorphisms on antiplatelet response to clopidogrel therapy in patients with coronary artery diseaseEffects of PON polymorphisms and haplotypes on molecular phenotype in Mexican-American mothers and children.A remarkable age-related increase in SIRT1 protein expression against oxidative stress in elderly: SIRT1 gene variants and longevity in humanDiminished antioxidant activity of high-density lipoprotein-associated proteins in systolic heart failureProtective effect of paraoxonase 1 gene variant Gln192Arg in age-related macular degeneration
P2860
Q24610194-32E3A561-E246-4FD8-AB9F-31B6B9438FAAQ24630160-689876BC-CF66-4764-978C-4E3E0BC2EE45Q26769994-6CBC02A9-6F49-49E7-97D6-206B338B3C24Q26775420-04582DD2-F15E-44C2-9849-247441A4775FQ26776188-01F5E3BA-24A9-4B15-A72A-64388DC308D3Q26777244-7F51B725-F8DA-4645-A772-FEFC77A78195Q26799214-E7F1F17D-D1F1-4A99-ADE3-7B7EED8DAE1DQ26824356-2AE6394D-2605-4FB4-AE8C-B934DD6CCB68Q26830910-43F42B24-23C3-41C7-8BE6-BDDE36813034Q26849832-8A99083D-EFA8-40D2-891F-8E528F455091Q26996600-3E4E474B-467C-46D8-84D4-F902A59991EBQ28283087-07BFC2C3-9E67-4BF5-895A-8A17AD311836Q28386822-DDEB8DEE-D71A-4F2F-B20E-00FA39E5CB62Q28388695-30357FD0-1254-43FD-992A-A97DB4112FF0Q28388799-7A68D6C5-F520-4F79-853E-355FAAEAB43DQ28392527-61F3656E-AF83-42F4-9805-BF5B1A858FF5Q28395898-9631C772-F490-43CA-974B-CF71F80B54D0Q28397671-430B3226-6D3C-46CE-9017-599C12010533Q28486151-184F4827-BD3B-4961-AAF1-F3E9669E5E1BQ30417352-F2412D42-6109-4CBF-95BE-3B357E686B6EQ30426824-B4A356FE-098D-42B7-AB73-EE899F0BB39CQ30446789-49E633B7-E38A-453A-9412-2F724BDCCE7AQ30655573-2BF4C8D1-1665-4062-B7B2-1098C971A38CQ30829280-E6E2554F-C05B-41C2-B9A3-A1C70025487EQ30891417-22772C8A-2939-4DDB-AC32-AC6E4675A2EAQ33497323-F9DC908C-814F-49EE-89F6-A69E4C188E21Q33608017-69E21F67-8692-4D77-884B-52C804755AF6Q33671228-74F5B7C2-4145-436E-A162-2797FBC0EBADQ33771715-EA60AE4E-52DC-47E1-9704-EF95778A4966Q33810410-3A377798-35C8-4092-BF3F-4360D69E36FCQ33976196-342DC6D2-0205-48B2-9E26-A3B61A14B981Q33995879-3FE81FDC-8A00-40B4-8E9B-8100C1BD3035Q34034892-39874DFB-2289-4328-B35A-78154FF3B13CQ34253260-D0ED8B3B-A35E-43DF-908C-6910A634F5CAQ34259215-4FED18C9-9A8E-41BD-9652-00D6470B249FQ34352152-E6DF252F-7A21-484B-AF2E-6C8CBCBEB045Q34414287-305B6793-870B-4222-8239-E8505720A7BFQ34467732-338CA200-C07B-45BA-9B83-ECFB5CFB579DQ34504604-E8C1EF56-BE78-435A-BBC1-E627892DE82EQ34518470-AFDC7DA3-E996-4657-8A97-0A7A2EA25E9D
P2860
Relationship of paraoxonase 1 (PON1) gene polymorphisms and functional activity with systemic oxidative stress and cardiovascular risk
description
2008 nî lūn-bûn
@nan
2008 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի մարտին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Relationship of paraoxonase 1 ...... stress and cardiovascular risk
@ast
Relationship of paraoxonase 1 ...... stress and cardiovascular risk
@en
Relationship of paraoxonase 1
@nl
type
label
Relationship of paraoxonase 1 ...... stress and cardiovascular risk
@ast
Relationship of paraoxonase 1 ...... stress and cardiovascular risk
@en
Relationship of paraoxonase 1
@nl
prefLabel
Relationship of paraoxonase 1 ...... stress and cardiovascular risk
@ast
Relationship of paraoxonase 1 ...... stress and cardiovascular risk
@en
Relationship of paraoxonase 1
@nl
P2093
P2860
P50
P356
P1476
Relationship of paraoxonase 1 ...... stress and cardiovascular risk
@en
P2093
David Schmitt
Hooman Allayee
Marie-Luise Brennan
Mingyuan Shao
Renliang Zhang
Stanley L Hazen
Stephen J Nicholls
Tamali Bhattacharyya
Xiaoming Fu
P2860
P304
P356
10.1001/JAMA.299.11.1265
P407
P577
2008-03-01T00:00:00Z